Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Lancet
; 400(10357): 1008-1019, 2022 09 24.
Article
in En
| MEDLINE
| ID: mdl-36108657
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Carcinoma, Merkel Cell
/
Radiosurgery
Type of study:
Clinical_trials
Limits:
Adolescent
/
Adult
/
Humans
Language:
En
Journal:
Lancet
Year:
2022
Document type:
Article
Country of publication:
United kingdom